Arena Pharmaceuticals logo
Arena Pharmaceuticals ARNA

Annual report 2021
added 12-16-2023

report update icon

Arena Pharmaceuticals DSO Ratio 2011-2026 | ARNA

Annual DSO Ratio Arena Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 946 1.53 75.6 193 59.4 47 36.6 47.5 73.5 17.4

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
946 1.53 150

Quarterly DSO Ratio Arena Pharmaceuticals

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - - 335 50.9 119 219 0.47 53.7 130 116 194 14 89.1 113 80.5 13.7 95.6 193 116 58.1 49.3 49 32.2 36.9 41.5 26.5 95.8 148 270 14 311 262 341 23.1 128 26.7 16 17 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
341 0.47 108

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.6 -1.64 % $ 8.66 B australiaAustralia
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
2.47 - - $ 546 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
70.9 $ 21.6 1.12 % $ 1.01 B usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
61.7 - - $ 25.3 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
62.9 $ 1.54 4.77 % $ 396 M usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
30 $ 0.82 -0.2 % $ 27.9 M israelIsrael
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 3.11 6.51 % $ 5.12 M israelIsrael
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.2 0.24 % $ 449 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 25.23 4.6 % $ 3.21 B usaUSA
Chimerix Chimerix
CMRX
588 - - $ 756 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
147 - - $ 401 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
321 $ 33.56 2.98 % $ 2.23 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.49 1.02 % $ 397 M britainBritain
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael